Clinical trial
Non-invasive Tools to Better Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Non-immunosuppressive Conditions.
NCT05138666 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-invasive Tools to Better Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Non-immunosuppressive Conditions.
- Lead sponsor
- Centre Hospitalier Universitaire de Besancon
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 16, 2022
- Completion date
- March 31, 2024
- Enrollment
- 363 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.